Bamias, A <br/><br/>
Neoadjuvant chemotherapy with docetaxel and cisplatin in patients with high-risk resectable bladder carcinoma: long term results.  [electronic resource] 

 -  European urology  Sep 2004 
 - 344-50; discussion 350-1 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0302-2838 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2004.04.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Chemotherapy, Adjuvant<br/>Cisplatin--therapeutic use<br/>Cystectomy<br/>Docetaxel<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Remission Induction<br/>Survival Analysis<br/>Taxoids--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--drug therapy